SCHEMBL5300149

SCHEMBL5300149

c1ccc(CN2CCC(Oc3ccccn3)CC2)cc1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 2/20 0.56
SCN9A Q15858 6/20 0.55
SCN5A Q14524 4/20 0.55
KCNH2 Q12809 2/20 0.55
HRH3 Q9Y5N1 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.52
GAA P10253 1/20 0.52
ROCK2 O75116 1/20 0.50
CCR2 P41597 1/20 0.50
ACHE P22303 1/20 0.50
SIGMAR1 Q99720 1/20 0.49
CCR3 P51677 1/20 0.49
DRD2 P14416 1/20 0.48
DRD4 P21917 1/20 0.48
DRD3 P35462 1/20 0.48
OPRK1 P41145 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6224824 0.87 ROCK1 (0.47) ROCK1SCN9ASCN5AKCNH2HRH3
SCHEMBL6225535 0.86 HRH3 (0.49) ROCK1SCN9ASCN5AKCNH2HRH3
SCHEMBL10819391 0.82 HRH3 (0.48) SCN9ASCN5AHRH3
SCHEMBL1306480 0.80 CARM1 (0.46) ROCK1SCN9ASCN5AKCNH2
SCHEMBL17455980 0.80 SMN1; SMN2 (0.58) ROCK1SCN9ASCN5AKCNH2HRH3
SCHEMBL1307334 0.79 EPHX2 (0.44) HRH3
SCHEMBL13683393 0.79 EPHX2 (0.44) HRH3
SCHEMBL4111325 0.79 SMN1; SMN2 (0.60) ROCK1SCN9ASCN5AKCNH2HRH3
SCHEMBL4110851 0.79 SCN9A (0.59) ROCK1SCN9ASCN5AKCNH2HRH3
SCHEMBL4855546 0.79 HRH3 (0.74) ROCK1HRH3SMN1; SMN2GAAROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1841758-A1 SUBSTITUTED TRIAZOLE DERIVATIVES AS OXYTOCIN ANTAGONISTS Pfizer Limited (GB) 2007-10-10 EP disclosed
WO-2006077496-A1 SUBSTITUTED TRIAZOLE DERIVATIVES AS OXYTOCIN ANTAGONISTS PFIZER LIMITED (GB) 2006-07-27 WO disclosed
US-5034401-A Cardiovascular disorders or antiischemia agents SYNTHELABO (FR) 1991-07-23 US disclosed